发明名称 |
UNITARY PHARMACEUTICAL DOSAGE FORM |
摘要 |
In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation. |
申请公布号 |
US2014037724(A1) |
申请公布日期 |
2014.02.06 |
申请号 |
US201314050714 |
申请日期 |
2013.10.10 |
申请人 |
BRISTOL-MYERS SQUIBB & GILEAD SCIENCES, LLC |
发明人 |
DAHL TERRENCE C.;HUSSAIN MUNIR A.;LIPPER ROBERT A.;JERZEWSKI ROBERT L.;MENNING MARK M.;OLIYAI REZA;YANG TAIYIN |
分类号 |
A61K31/683;A61K31/513;A61K31/536 |
主分类号 |
A61K31/683 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|